Exacerbation of Secondary Cold Agglutinin Syndrome in the Setting of SARS-CoV-2

Copyright © 2021, Bhagat et al..

In this report, we present a case of exacerbation of cold agglutinin syndrome (CAS) potentially due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia. An 83-year-old female with a history of cold agglutinin hemolytic anemia presented with shortness of breath, productive cough, worsening orthopnea, darkening fingers and urine, and jaundice. Laboratory investigations found elevated white blood cells (WBC) and total bilirubin, severely low hemoglobin, and positive direct Coombs test. Moreover, SARS-CoV-2 RNA was also found to be positive in a sample from the nasal swab by reverse transcription-polymerase chain reaction (RT-PCR), indicating exacerbation of CAS secondary to viral coronavirus 2019 (COVID-19) infection. A treatment regime for SARS-CoV-2 consisting of five days of remdesivir and seven days of dexamethasone 6 mg IV was initiated, resulting in significant improvement in the patient's condition.

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:13

Enthalten in:

Cureus - 13(2021), 11 vom: 30. Nov., Seite e19387

Sprache:

Englisch

Beteiligte Personen:

Bhagat, Yash V [VerfasserIn]
Hussien, Siham [VerfasserIn]
Queenan, Helen [VerfasserIn]
Michael, Miriam B [VerfasserIn]

Links:

Volltext

Themen:

Autoimmune hemolytic anemia (aiha)
Case Reports
Cold agglutinin syndrome
Covid coagulopathy
Covid hypercoagulability
Covid-19
Covid-19 associated coagulopathy
Covid-19 pneumonia
Sars-cov-2
Severe acute respiratory syndrome coronavirus-2 (sars-cov-2)
Transfusion in covid 19 pandemic

Anmerkungen:

Date Revised 21.12.2021

published: Electronic-eCollection

Citation Status PubMed-not-MEDLINE

doi:

10.7759/cureus.19387

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM334620406